Advances on the Genetics of Mendelian Idiopathic Epilepsies

Clinics in Laboratory Medicine

Volumn 30, Issue 4, 2010, Pages 911-929

  Baulac, Stéphanie ^a   Baulac, Michel ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Epilepsy; Febrile seizures; Genes; Idiopathic; Loci

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR ALPHA1; 4 AMINOBUTYRIC ACID A RECEPTOR GAMMA2; NICOTINIC RECEPTOR ALPHA4; NICOTINIC RECEPTOR BETA2; POTASSIUM CHANNEL KCNQ2; POTASSIUM CHANNEL KCNQ3; RETIGABINE; SCN1B PROTEIN; SODIUM CHANNEL; SODIUM CHANNEL NAV1.1; SODIUM CHANNEL NAV1.2; UNCLASSIFIED DRUG;

ABSENCE; AUTOSOMAL DOMINANT LATERAL TEMPORAL LOBE EPILEPSY; AUTOSOMAL DOMINANT NOCTURNAL FRONTAL LOBE EPILEPSY; BENIGN FAMILIAL INFANTILE SEIZURE; BENIGN FAMILIAL NEONATAL INFANTILE SEIZURE; BENIGN FAMILIAL NEONATAL SEIZURE; CHROMOSOME 19; CHROMOSOME 2; CHROMOSOME 21; CHROMOSOME 6; CHROMOSOME 8; CLINICAL TRIAL; DRUG TARGETING; EPILEPSY; EPILEPTOGENESIS; FAMILIAL MESIAL TEMPORAL LOBE EPILEPSY; FAMILIAL PARTIAL EPILEPSY WITH VARIABLE FOCUS; FEBRILE CONVULSION; GENE IDENTIFICATION; GENE LOCUS; GENE MUTATION; GENERALIZED EPILEPSY WITH FEBRILE SEIZURE; GENETIC HETEROGENEITY; GENETIC SUSCEPTIBILITY; HIGH THROUGHPUT SCREENING; HUMAN; JUVENILE MYOCLONIC EPILEPSY; MOLECULAR GENETICS; NONHUMAN; ONSET AGE; PENETRANCE; PRIORITY JOURNAL; REVIEW; SEIZURE; SINGLE NUCLEOTIDE POLYMORPHISM;

EPILEPSY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HUMANS;

EID: 77956544846     PISSN: 02722712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cll.2010.07.008     Document Type: Review

References (117)

1. Steinlein O.K., Mulley J.C., Propping P., et al. A missense mutation in the neuronal nicotinic acetylcholine receptor alpha 4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy. Nat Genet 1995, 11:201-203.
2. Kalachikov S., Evgrafov O., Ross B., et al. Mutations in LGI1 cause autosomal-dominant partial epilepsy with auditory features. Nat Genet 2002, 30:335-341.
3. Morante-Redolat J.M., Gorostidi-Pagola A., Piquer-Sirerol S., et al. Mutations in the LGI1/Epitempin gene on 10q24 cause autosomal dominant lateral temporal epilepsy. Hum Mol Genet 2002, 11:1119-1128.
4. Deprez L., Jansen A., De Jonghe P. Genetics of epilepsy syndromes starting in the first year of life. Neurology 2009, 72:273-281.
5. Singh N.A., Charlier C., Stauffer D., et al. A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns. Nat Genet 1998, 18:25-29.
6. Biervert C., Schroeder B.C., Kubisch C., et al. A potassium channel mutation in neonatal human epilepsy. Science 1998, 279:403-406.
7. Charlier C., Singh N.A., Ryan S.G., et al. A pore mutation in a novel KQT-like potassium channel gene in an idiopathic epilepsy family. Nat Genet 1998, 18:53-55.
8. Soldovieri M.V., Miceli F., Bellini G., et al. Correlating the clinical and genetic features of benign familial neonatal seizures (BFNS) with the functional consequences of underlying mutations. Channels (Austin) 2007, 1:228-233.
9. Claes L.R., Ceulemans B., Audenaert D., et al. De novo KCNQ2 mutations in patients with benign neonatal seizures. Neurology 2004, 63:2155-2158.
10. Ishii A., Fukuma G., Uehara A., et al. A de novo KCNQ2 mutation detected in non-familial benign neonatal convulsions. Brain Dev 2009, 31:27-33.
11. Singh N.A., Westenskow P., Charlier C., et al. KCNQ2 and KCNQ3 potassium channel genes in benign familial neonatal convulsions: expansion of the functional and mutation spectrum. Brain 2003, 126:2726-2737.
12. Herlenius E., Heron S.E., Grinton B.E., et al. SCN2A mutations and benign familial neonatal-infantile seizures: the phenotypic spectrum. Epilepsia 2007, 48:1138-1142.
13. Berkovic S.F., Heron S.E., Giordano L., et al. Benign familial neonatal-infantile seizures: characterization of a new sodium channelopathy. Ann Neurol 2004, 55:550-557.
14. Heron S.E., Crossland K.M., Andermann E., et al. Sodium-channel defects in benign familial neonatal-infantile seizures. Lancet 2002, 360:851-852.
15. Liao Y., Deprez L., Maljevic S., et al. Molecular correlates of age-dependent seizures in an inherited neonatal-infantile epilepsy. Brain 2010, 133:1403-1414.
16. Vigevano F., Bureau M. Idiopathic and/or benign localization-related epilepsies in infants and young children. Epileptic syndromes in infancy, childhood and adolescence 2002, 171-179. John Libbey, Eastleigh (UK), Chapter 12. 3rd edition. J. Roger, M. Bureau, C. Dravet (Eds.).
17. Guipponi M., Rivier F., Vigevano F., et al. Linkage mapping of benign familial infantile convulsions (BFIC) to chromosome 19q. Hum Mol Genet 1997, 6:473-477.
18. Caraballo R., Pavek S., Lemainque A., et al. Linkage of benign familial infantile convulsions to chromosome 16p12-q12 suggests allelism to the infantile convulsions and choreoathetosis syndrome. Am J Hum Genet 2001, 68:788-794.
19. Callenbach P.M., van den Boogerd E.H., de Coo R.F., et al. Refinement of the chromosome 16 locus for benign familial infantile convulsions. Clin Genet 2005, 67:517-525.
20. Szepetowski P., Rochette J., Berquin P., et al. Familial infantile convulsions and paroxysmal choreoathetosis: a new neurological syndrome linked to the pericentromeric region of human chromosome 16. Am J Hum Genet 1997, 61:889-898.
21. Hauser W.A. The prevalence and incidence of convulsive disorders in children. Epilepsia 1994, 35(Suppl 2):S1-S6.
22. Tsuboi T. Epidemiology of febrile and afebrile convulsions in children in Japan. Neurology 1984, 34:175-181.
23. Annegers J.F., Hauser W.A., Elveback L.R., et al. The risk of epilepsy following febrile convulsions. Neurology 1979, 29:297-303.
24. Scheffer I.E., Berkovic S.F. Generalized epilepsy with febrile seizures plus. A genetic disorder with heterogeneous clinical phenotypes. Brain 1997, 120(Pt 3):479-490.
25. Johnson W.G., Kugler S.L., Stenroos E.S., et al. Pedigree analysis in families with febrile seizures. Am J Med Genet 1996, 61:345-352.
26. +-channel beta1 subunit gene SCN1B. Nat Genet 1998, 19:366-370.
27. Escayg A., MacDonald B.T., Meisler M.H., et al. Mutations of SCN1A, encoding a neuronal sodium channel, in two families with GEFS+2. Nat Genet 2000, 24:343-345.
28. Baulac S., Huberfeld G., Gourfinkel-An I., et al. First genetic evidence of GABA(A) receptor dysfunction in epilepsy: a mutation in the gamma2-subunit gene. Nat Genet 2001, 28:46-48.
29. Nakayama J. Progress in searching for the febrile seizure susceptibility genes. Brain Dev 2009, 31:359-365.
30. Johnson E.W., Dubovsky J., Rich S.S., et al. Evidence for a novel gene for familial febrile convulsions, FEB2, linked to chromosome 19p in an extended family from the Midwest. Hum Mol Genet 1998, 7:63-67.
31. Kugler S.L., Stenroos E.S., Mandelbaum D.E., et al. Hereditary febrile seizures: phenotype and evidence for a chromosome 19p locus. Am J Med Genet 1998, 79:354-361.
32. Nabbout R., Prud'homme J.F., Herman A., et al. A locus for simple pure febrile seizures maps to chromosome 6q22-q24. Brain 2002, 125:2668-2680.
33. Wallace R.H., Berkovic S.F., Howell R.A., et al. Suggestion of a major gene for familial febrile convulsions mapping to 8q13-21. J Med Genet 1996, 33:308-312.
34. Peiffer A., Thompson J., Charlier C., et al. A locus for febrile seizures (FEB3) maps to chromosome 2q23-24. Ann Neurol 1999, 46:671-678.
35. Singh N.A., Pappas C., Dahle E.J., et al. A role of SCN9A in human epilepsies, as a cause of febrile seizures and as a potential modifier of Dravet syndrome. PLoS Genet 2009, 5:e1000649.
36. Hedera P., Ma S., Blair M.A., et al. Identification of a novel locus for febrile seizures and epilepsy on chromosome 21q22. Epilepsia 2006, 47:1622-1628.
37. Nabbout R., Baulac S., Desguerre I., et al. New locus for febrile seizures with absence epilepsy on 3p and a possible modifier gene on 18p. Neurology 2007, 68:1374-1381.
38. Nakayama J., Yamamoto N., Hamano K., et al. Linkage and association of febrile seizures to the IMPA2 gene on human chromosome 18. Neurology 2004, 63:1803-1807.
39. Dai X.H., Chen W.W., Wang X., et al. A novel genetic locus for familial febrile seizures and epilepsy on chromosome 3q26.2-q26.33. Hum Genet 2008, 124:423-429.
40. Singh R., Scheffer I.E., Crossland K., et al. Generalized epilepsy with febrile seizures plus: a common childhood-onset genetic epilepsy syndrome. Ann Neurol 1999, 45:75-81.
41. Scheffer I. Epilepsy: a comprehensive textbook 2008, 2553-2558. Lippincott, Williams & Wilkins, Philadelphia. J.J. Engel, T.A. Pedley (Eds.).
42. Wallace R.H., Scheffer I.E., Parasivam G., et al. Generalized epilepsy with febrile seizures plus: mutation of the sodium channel subunit SCN1B. Neurology 2002, 58:1426-1429.
43. Scheffer I.E., Harkin L.A., Grinton B.E., et al. Temporal lobe epilepsy and GEFS+ phenotypes associated with SCN1B mutations. Brain 2007, 130:100-109.
44. Meadows L.S., Malhotra J., Loukas A., et al. Functional and biochemical analysis of a sodium channel beta1 subunit mutation responsible for generalized epilepsy with febrile seizures plus type 1. J Neurosci 2002, 22:10699-10709.
45. Audenaert D., Claes L., Ceulemans B., et al. A deletion in SCN1B is associated with febrile seizures and early-onset absence epilepsy. Neurology 2003, 61:854-856.
46. Baulac S., Gourfinkel-An I., Picard F., et al. A second locus for familial generalized epilepsy with febrile seizures plus maps to chromosome 2q21-q33. Am J Hum Genet 1999, 65:1078-1085.
47. Moulard B., Guipponi M., Chaigne D., et al. Identification of a new locus for generalized epilepsy with febrile seizures plus (GEFS+) on chromosome 2q24-q33. Am J Hum Genet 1999, 65:1396-1400.
48. Lossin C. A catalog of SCN1A variants. Brain Dev 2009, 31:114-130.
49. Claes L., Del-Favero J., Ceulemans B., et al. De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy. Am J Hum Genet 2001, 68:1327-1332.
50. Dravet C., Bureau M., Oguni H., et al. Severe myoclonic epilepsy in infancy: Dravet syndrome. Adv Neurol 2005, 95:71-102.
51. Depienne C., Trouillard O., Saint-Martin C., et al. Spectrum of SCN1A gene mutations associated with Dravet syndrome: analysis of 333 patients. J Med Genet 2009, 46:183-191.
52. Depienne C., Arzimanoglou A., Trouillard O., et al. Parental mosaicism can cause recurrent transmission of SCN1A mutations associated with severe myoclonic epilepsy of infancy. Hum Mutat 2006, 27:389.
53. Marini C., Mei D., Helen Cross J., et al. Mosaic SCN1A mutation in familial severe myoclonic epilepsy of infancy. Epilepsia 2006, 47:1737-1740.
54. Morimoto M., Mazaki E., Nishimura A., et al. SCN1A mutation mosaicism in a family with severe myoclonic epilepsy in infancy. Epilepsia 2006, 47:1732-1736.
55. Gennaro E., Santorelli F.M., Bertini E., et al. Somatic and germline mosaicisms in severe myoclonic epilepsy of infancy. Biochem Biophys Res Commun 2006, 341:489-493.
56. Wallace R.H., Marini C., Petrou S., et al. Mutant GABA(A) receptor gamma2-subunit in childhood absence epilepsy and febrile seizures. Nat Genet 2001, 28:49-52.
57. Harkin L.A., Bowser D.N., Dibbens L.M., et al. Truncation of the GABA(A)-receptor gamma2 subunit in a family with generalized epilepsy with febrile seizures plus. Am J Hum Genet 2002, 70:530-536.
58. Kananura C., Haug K., Sander T., et al. A splice-site mutation in GABRG2 associated with childhood absence epilepsy and febrile convulsions. Arch Neurol 2002, 59:1137-1141.
59. Audenaert D., Schwartz E., Claeys K.G., et al. A novel GABRG2 mutation associated with febrile seizures. Neurology 2006, 67:687-690.
60. Audenaert D., Claes L., Claeys K.G., et al. A novel susceptibility locus at 2p24 for generalised epilepsy with febrile seizures plus. J Med Genet 2005, 42:947-952.
61. Baulac S., Gourfinkel-An I., Couarch P., et al. A novel locus for generalized epilepsy with febrile seizures plus in French families. Arch Neurol 2008, 65:943-951.
62. Poduri A., Wang Y., Gordon D., et al. Novel susceptibility locus at chromosome 6q16.3-22.31 in a family with GEFS+. Neurology 2009, 73:1264-1272.
63. Baulac S., Gourfinkel-An I., Nabbout R., et al. Fever, genes, and epilepsy. Lancet Neurol 2004, 3:421-430.
64. Sijben A.E., Sithinamsuwan P., Radhakrishnan A., et al. Does a SCN1A gene mutation confer earlier age of onset of febrile seizures in GEFS+?. Epilepsia 2009, 50:953-956.
65. Scheffer I.E., Bhatia K.P., Lopes-Cendes I., et al. Autosomal dominant frontal epilepsy misdiagnosed as sleep disorder. Lancet 1994, 343:515-517.
66. Scheffer I.E., Bhatia K.P., Lopes-Cendes I., et al. Autosomal dominant nocturnal frontal lobe epilepsy. A distinctive clinical disorder. Brain 1995, 118(Pt 1):61-73.
67. Marini C., Guerrini R. The role of the nicotinic acetylcholine receptors in sleep-related epilepsy. Biochem Pharmacol 2007, 74:1308-1314.
68. Phillips H.A., Marini C., Scheffer I.E., et al. A de novo mutation in sporadic nocturnal frontal lobe epilepsy. Ann Neurol 2000, 48:264-267.
69. Chen Y., Wu L., Fang Y., et al. A novel mutation of the nicotinic acetylcholine receptor gene CHRNA4 in sporadic nocturnal frontal lobe epilepsy. Epilepsy Res 2009, 83:152-156.
70. De Fusco M., Becchetti A., Patrignani A., et al. The nicotinic receptor beta 2 subunit is mutant in nocturnal frontal lobe epilepsy. Nat Genet 2000, 26:275-276.
71. Phillips H.A., Favre I., Kirkpatrick M., et al. CHRNB2 is the second acetylcholine receptor subunit associated with autosomal dominant nocturnal frontal lobe epilepsy. Am J Hum Genet 2001, 68:225-231.
72. Diaz-Otero F., Quesada M., Morales-Corraliza J., et al. Autosomal dominant nocturnal frontal lobe epilepsy with a mutation in the CHRNB2 gene. Epilepsia 2008, 49:516-520.
73. Cho Y.W., Yi S.D., Lim J.G., et al. Autosomal dominant nocturnal frontal lobe epilepsy and mild memory impairment associated with CHRNB2 mutation I312M in the neuronal nicotinic acetylcholine receptor. Epilepsy Behav 2008, 13:361-365.
74. Aridon P., Marini C., Di Resta C., et al. Increased sensitivity of the neuronal nicotinic receptor alpha 2 subunit causes familial epilepsy with nocturnal wandering and ictal fear. Am J Hum Genet 2006, 79:342-350.
75. Gu W., Bertrand D., Steinlein O.K. A major role of the nicotinic acetylcholine receptor gene CHRNA2 in autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) is unlikely. Neurosci Lett 2007, 422:74-76.
76. Combi R., Ferini-Strambi L., Tenchini M.L. CHRNA2 mutations are rare in the NFLE population: evaluation of a large cohort of Italian patients. Sleep Med 2009, 10:139-142.
77. De Marco E.V., Gambardella A., Annesi F., et al. Further evidence of genetic heterogeneity in families with autosomal dominant nocturnal frontal lobe epilepsy. Epilepsy Res 2007, 74:70-73.
78. Phillips H.A., Scheffer I.E., Crossland K.M., et al. Autosomal dominant nocturnal frontal-lobe epilepsy: genetic heterogeneity and evidence for a second locus at 15q24. Am J Hum Genet 1998, 63:1108-1116.
79. Bonati M.T., Asselta R., Duga S., et al. Refined mapping of CHRNA3/A5/B4 gene cluster and its implications in ADNFLE. Neuroreport 2000, 11:2097-2101.
80. Winawer M.R., Ottman R., Hauser W.A., et al. Autosomal dominant partial epilepsy with auditory features: defining the phenotype. Neurology 2000, 54:2173-2176.
81. Ottman R., Risch N., Hauser W.A., et al. Localization of a gene for partial epilepsy to chromosome 10q. Nat Genet 1995, 10:56-60.
82. Nobile C., Michelucci R., Andreazza S., et al. LGI1 mutations in autosomal dominant and sporadic lateral temporal epilepsy. Hum Mutat 2009, 30:530-536.
83. Chabrol E., Popescu C., Gourfinkel-An I., et al. Two novel epilepsy-linked mutations leading to a loss of function of LGI1. Arch Neurol 2007, 64:217-222.
84. Striano P., de Falco A., Diani E., et al. A novel loss-of-function LGI1 mutation linked to autosomal dominant lateral temporal epilepsy. Arch Neurol 2008, 65:939-942.
85. Sirerol-Piquer M.S., Ayerdi-Izquierdo A., Morante-Redolat J.M., et al. The epilepsy gene LGI1 encodes a secreted glycoprotein that binds to the cell surface. Hum Mol Genet 2006, 15:3436-3445.
86. Senechal K.R., Thaller C., Noebels J.L. ADPEAF mutations reduce levels of secreted LGI1, a putative tumor suppressor protein linked to epilepsy. Hum Mol Genet 2005, 14:1613-1620.
87. de Bellescize J., Boutry N., Chabrol E., et al. A novel three base-pair LGI1 deletion leading to loss of function in a family with autosomal dominant lateral temporal epilepsy and migraine-like episodes. Epilepsy Res 2009, 85:118-122.
88. Staub E., Perez-Tur J., Siebert R., et al. The novel EPTP repeat defines a superfamily of proteins implicated in epileptic disorders. Trends Biochem Sci 2002, 27:441-444.
89. Head K., Gong S., Joseph S., et al. Defining the expression pattern of the LGI1 gene in BAC transgenic mice. Mamm Genome 2007, 18:328-337.
90. Chernova O.B., Somerville R.P., Cowell J.K. A novel gene, LGI1, from 10q24 is rearranged and downregulated in malignant brain tumors. Oncogene 1998, 17:2873-2881.
91. Schulte U., Thumfart J.O., Klocker N., et al. The epilepsy-linked Lgi1 protein assembles into presynaptic Kv1 channels and inhibits inactivation by Kvbeta1. Neuron 2006, 49:697-706.
92. Fukata Y., Adesnik H., Iwanaga T., et al. Epilepsy-related ligand/receptor complex LGI1 and ADAM22 regulate synaptic transmission. Science 2006, 313:1792-1795.
93. Fukata Y., Lovero K.L., Iwanaga T., et al. Disruption of LGI1-linked synaptic complex causes abnormal synaptic transmission and epilepsy. Proc Natl Acad Sci U S A 2010, 107:3799-3804.
94. Yu Y.E., Wen L., Silva J., et al. Lgi1 null mutant mice exhibit myoclonic seizures and CA1 neuronal hyperexcitability. Hum Mol Genet 2010, 19:1702-1711.
95. Chabrol E., Navarro V., Provenzano G., et al. Electro-clinical characterization of epileptic seizures in LGI1-deficient mice. Brain 2010, [Epub ahead of print].
96. Berkovic S.F., McIntosh A., Howell R.A., et al. Familial temporal lobe epilepsy: a common disorder identified in twins. Ann Neurol 1996, 40:227-235.
97. Baulac S., Picard F., Herman A., et al. Evidence for digenic inheritance in a family with both febrile convulsions and temporal lobe epilepsy implicating chromosomes 18qter and 1q25-q31. Ann Neurol 2001, 49:786-792.
98. Claes L., Audenaert D., Deprez L., et al. Novel locus on chromosome 12q22-q23.3 responsible for familial temporal lobe epilepsy associated with febrile seizures. J Med Genet 2004, 41:710-714.
99. Hedera P., Blair M.A., Andermann E., et al. Familial mesial temporal lobe epilepsy maps to chromosome 4q13.2-q21.3. Neurology 2007, 68:2107-2112.
100. Striano P., Gambardella A., Coppola A., et al. Familial mesial temporal lobe epilepsy (FMTLE): a clinical and genetic study of 15 Italian families. J Neurol 2008, 255:16-23.
101. Scheffer I.E., Phillips H.A., O'Brien C.E., et al. Familial partial epilepsy with variable foci: a new partial epilepsy syndrome with suggestion of linkage to chromosome 2. Ann Neurol 1998, 44:890-899.
102. Xiong L., Labuda M., Li D.S., et al. Mapping of a gene determining familial partial epilepsy with variable foci to chromosome 22q11-q12. Am J Hum Genet 1999, 65:1698-1710.
103. Callenbach P.M., van den Maagdenberg A.M., Hottenga J.J., et al. Familial partial epilepsy with variable foci in a Dutch family: clinical characteristics and confirmation of linkage to chromosome 22q. Epilepsia 2003, 44:1298-1305.
104. Berkovic S.F., Serratosa J.M., Phillips H.A., et al. Familial partial epilepsy with variable foci: clinical features and linkage to chromosome 22q12. Epilepsia 2004, 45:1054-1060.
105. Cossette P., Liu L., Brisebois K., et al. Mutation of GABRA1 in an autosomal dominant form of juvenile myoclonic epilepsy. Nat Genet 2002, 31:184-189.
106. Ma S., Blair M.A., Abou-Khalil B., et al. Mutations in the GABRA1 and EFHC1 genes are rare in familial juvenile myoclonic epilepsy. Epilepsy Res 2006, 71:129-134.
107. Ratnapriya R., Vijai J., Kadandale J.S., et al. A locus for juvenile myoclonic epilepsy maps to 2q33-q36. Hum Genet 2010, 128:123-130.
108. Haug K., Warnstedt M., Alekov A.K., et al. Mutations in CLCN2 encoding a voltage-gated chloride channel are associated with idiopathic generalized epilepsies. Nat Genet 2003, 33:527-532.
109. Suzuki T., Delgado-Escueta A.V., Aguan K., et al. Mutations in EFHC1 cause juvenile myoclonic epilepsy. Nat Genet 2004, 36:842-849.
110. Greenberg D.A., Pal D.K. The state of the art in the genetic analysis of the epilepsies. Curr Neurol Neurosci Rep 2007, 7:320-328.
111. Ogiwara I., Miyamoto H., Morita N., et al. Na(v)1.1 localizes to axons of parvalbumin-positive inhibitory interneurons: a circuit basis for epileptic seizures in mice carrying an Scn1a gene mutation. J Neurosci 2007, 27:5903-5914.
112. Mashimo T., Ohmori I., Ouchida M., et al. A missense mutation of the gene encoding voltage-dependent sodium channel (Nav1.1) confers susceptibility to febrile seizures in rats. J Neurosci 2010, 30:5744-5753.
113. Martin M.S., Dutt K., Papale L.A., et al. Altered function of the SCN1A voltage-gated sodium channel leads to gamma-aminobutyric acid-ergic (GABAergic) interneuron abnormalities. J Biol Chem 2010, 285:9823-9834.
114. Rogawski M.A., Loscher W. The neurobiology of antiepileptic drugs. Nat Rev Neurosci 2004, 5:553-564.
115. Porter R.J., Partiot A., Sachdeo R., et al. Randomized, multicenter, dose-ranging trial of retigabine for partial-onset seizures. Neurology 2007, 68:1197-1204.
116. Lynch B.A., Lambeng N., Nocka K., et al. The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. Proc Natl Acad Sci U S A 2004, 101:9861-9866.
117. 2+ regulators in neurotransmitter release. Neuron 1999, 24:1003-1016.